Dallas, TX (PRWEB) July 04, 2014
The North American interventional cardiology and peripheral vascular devices market is expected to grow at a CAGR of 2.9% from 2013 to 2018. Both, the lower volume of coronary angioplasty procedures and the increasing prevalence rate of peripheral artery diseases have impacted the market significantly.
Amongst all the product segments, bioabsorbable stents, retrievable inferior vena cava filters, and diagnostic catheters (intravascular ultrasound and optical coherence tomography catheters) markets are identified as the high growth segments in the North American interventional cardiology and peripheral vascular devices market. Complete report is available at http://www.lifescienceindustryresearch.com/north-american-interventional-cardiology-peripheral-vascular-devices-market-by-angioplasty-balloon-plainold-cutting-stent-bioabsorbable-drug-eluting-catheter-ivus-oct-ivc-filter-retrie.html. Better diagnosis of thrombus using IVUS and OCT catheters is expected to drive the diagnostic catheters market; whereas, lesser risk of long-term post surgical complications in DVT/PE treatments will encourage faster adoption of the retrievable inferior vena cava filters in the coming years. The bioabsorbable stents are still not available for clinical usage in the U.S. However, bioabsorbable stents are available on a special access basis by Health Canada.
The usage factors of different surgical instruments were the major hindrances while deriving the market size of the corresponding surgical devices. This is primarily due to the availability of various surgical instruments for the treatment of similar cardiac ailments. For instance, coronary angioplasty can be performed through plain balloon catheter, stent, and/or a combination of stent and catheter, based on patients’ cardiac health.
The study on the North American interventional cardiology and peripheral vascular devices market captures an exhaustive list of surgical devices which are used in various types of angioplasty procedures, deep vein thrombosis, endovascular aneurysm repairing, and chronic total occlusion (CTO) treatment procedures. This research illustrates specific driving and restraining factors in the U.S. and Canadian markets; furthermore, it identifies the high-growth regions with regard to the interventional cardiology and peripheral vascular devices market. This extensive study provides an analytical comparison of the key players in terms of their segmental revenue and related portfolio and their respective market shares in the U.S. and Canadian market spaces in 2013. In a nutshell, this research intends to capture all facets of the North American interventional cardiology and peripheral vascular devices market to put forward approachable market solutions for leading players as well as new entrants.
Companies profiled in the North American interventional cardiology & peripheral vascular devices market report include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. Kg, Boston Scientific Corporation, Cook Medical, Inc., Cordis Corporation, Covidien PLC, C. R. Bard, Inc., W.L.Gore & Associates, Inc. and Medtronic Inc. Order a copy of this report at http://www.lifescienceindustryresearch.com/purchase?rname=14406.
Market drivers discussed in this report include increasing peripheral interventional procedures, double-digit growth in aging population, significant increase in pci centers in the U.S. and long waiting periods for care in Canada encourage patients to opt for mis procedures and new CPT codes to boost complex stenting procedures. The geographical analysis provided in this report highlights the following for:
- United States: over 20% growth in pci facilities to drive technology adoption, consistent growth in peripheral intervention procedures drive the market momentum, lower volume of pci procedures remains a major concern and stringent regulations to restrict market growth.
- Canada: lesser risk of restenosis to drive the future market momentum, poor infrastructure to hinder the adoption of interventional cardiology technologies and growth in aging population and lifestyle diseases to propel the interventional cardiology market.
Explore more reports on the medical devices industry at http://www.lifescienceindustryresearch.com/category/medical-devices.
Life Science Industry Research brings to you to the latest reports in market research on Biotechnology, Diagnostics, Healthcare, Medical Devices and Pharmaceuticals segments from leading research publishers across the globe. These reports also cover data and information on sub-segments and sectors under these life sciences categories.
Contact us (sales(at)lifescienceindustryresearch(dot)com / + 1 888 391 5441) for any of your research requirements or topics of interest. Our sales & research associates will be happy to help you find relevant market data.